Healthy Male Volunteer Clinical Trial
Official title:
A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers
Study Design : randomized, open label, single-dose, 2-way cross-over design
Phase : Phase I
n/a
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01442532 -
A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam
|
Phase 1 | |
| Completed |
NCT01133431 -
The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea
|
Phase 1 | |
| Completed |
NCT00859352 -
AZD1981 Midazolam CYP4503A Induction Study
|
Phase 1 | |
| Completed |
NCT02233218 -
The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
|
Phase 1 |